ZYDUSLIFE
Zydus Lifesciences Limited
Pharmaceuticals
Share price
₹1,200
Market cap
₹1.2L Cr
1Y return
▲ 29%
A vertically integrated pharmaceutical company, Zydus Lifesciences develops, manufactures, and markets generic drugs, specialty pharmaceuticals, and biologics for domestic and international markets. The company operates across multiple therapeutic areas including cardiology, gastroenterology, oncology, and immunology. It serves patients globally through its extensive distribution network, research capabilities, and commitment to addressing unmet healthcare needs across diverse populations and geographies.
Investors holding Zydus Lifesciences Limited
Recent moves 9
1move in the last 30 days
Members onlyKotak Mutual FundDecreased
Kotak Mutual Fund decreased its stake in Zydus Lifesciences from 1.19% to 1.07%, selling 12,26,979 shares.
Read more
PPFAS Mutual FundDecreased
PPFAS Mutual Fund decreased its stake in Zydus Lifesciences from 2.02% to 2.01%, selling 58,129 shares.
Read more
LICDecreased
LIC decreased its stake in Zydus Lifesciences from 5.41% to 3.77%, reducing its holding from 5,39,71,802 to 3,75,91,984 shares.
Read more
Quant Mutual FundNew position
Quant Mutual Fund entered Zydus Lifesciences, acquiring 1,48,47,839 shares representing a 1.49% stake. The position was built through a rights issue.
Read more
Prashant Babubhai PatelNew position
Promoter Group member Prashant Babubhai Patel acquired 32,577 shares of Zydus Lifesciences via transmission on August 19, 2026. This acquisition, categorized under Regulation 7 (2) updates, increased his holding from 0 to 32,577 shares. The shares were transferred from the estate of Late Jasodaben Babubhai Patel.
Read more
LICDecreased
LIC decreased its stake in Zydus Lifesciences from 5.56% to 5.41%, selling 19.37 lakh shares.
Read more
Kotak Mutual FundIncreased
Kotak Mutual Fund increased its stake in Zydus Lifesciences from 1.13% to 1.19%, raising its shareholding from 1,13,97,485 to 1,19,11,788 shares.
Read more
PPFAS Mutual FundIncreased
PPFAS Mutual Fund increased its stake in Zydus Lifesciences from 1.96% to 2.02%, acquiring 471,413 additional shares. This change reflects an increased position in the company.
Read more
Track the whales in Zydus Lifesciences Limited
Get alerted the moment a top investor buys or sells.
Start 7 days for ₹1